Ohm, your response to my statement, "You do realize that

New Post Public Reply Private Reply Replies (2) Message Board
Cassandra X ohm20 #137739
501
Ohm, your response to my statement, "You do realize that AIs will eliminate the need for all drug trials - mouse, monkey and human? All drug trialing will be done virtually" was a surprise to me.

You say that such a thing would be "a recipe for disaster." Then you proceed to say why. Let's dissect those reasons why.

First off, how could it be a disaster when no one is going to do trialing with AI until it is ready for "Prime Time" as SamaGong says?

I'm surprised at the catagorical nature of some statements about AI trialing, such as it will "never" happen. craigakess says AI can never be smarter than we are and will only "augment" drug trials and AI will never know how a new drug molecule will act in the body.

You say a similar thing, that AI is only as good as the information it is fed and that "some medical papers are flat out wrong."

But there is no Chinese Wall between how humans learn or are "trained" and how AI learns. It takes in information, as humans do, and then correlates and corroborates that information. Non-conforming data is subjected to scrutiny and correction, especially as programmers and users are right there to point out to AI what it may get wrong. AI learns just as we do what is true and not true.

Further, AI can be set to testing things it deems to be true or postulated to be true, just as humans do. AI can do trial and error. Hell, even evolution does that. Those things that are true have "survival value" and are cached and those that do not are discarded. A machine is totally capable of that.

Drug trialing is just chemistry and is as knowable as math, though much more multi-dimensional. If AI gets chemistry wrong, it does so FOR THE VERY SAME REASONS humans would make mistakes - not complete enough information. It can seek to know what it does not already know.

There is nothing human brains can do that AI "brains" cannot do. They are faster, they never forget, they can learn from their mistakes and they can learn new things. Just like humans do. Given time, it might even develop "feeling," "see" colors and enjoy music. These are emergent properties that our ancestral minds did not have until they evolved further.

We have to recognize that there is a time element to all of this, of course. Some people say "never", some people are more flexible and say there will be a "Prime Time" some time, Respert24 says "not in our lifetime."

But AI is absolutely being used today in medicine and other fields as it learns to walk before it can run.

As it can be applied to your list of diseases Leronlimab might treat, every disease has a constellation of cells, organs, receptors and cytokines associated with it, especially CCR5, of course. Just as you have researched those constellations of characteristics, so can AI and it will see patterns and correlations and will corroborate research results about them.

As time goes on it will model biological system such as cells in petri dishes, then mice and, later, even humans and it will do testing of drugs on those models such as Leronlimab. It's all a matter of time.

You say "AI can provide possibilities but it does not contain any actual wisdom or discernment." You will be proven wrong there.

May I cite the wisdom of the "Whopper" computer in the movie "War Games," a terrific movie that everyone should be encouraged to watch.

In the movie, Global Nuclear War was simulated like a game as humans stood by helplessly. After running its simulations, the computer came up with the WISDOM to say that "The only way to win the game is not to play." Yes, a computer can figure that out! That and much more.






CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 51

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
RBI Prices $1 Billion of Secured Notes Due 2031, 2036

Updated Category News Views 222

A billion dollars of fresh paper just landed on Restaurant Brands International’s balance-sheet doorstep, and this one deserves more than the usual sleepy glance at a financing release. RBI has priced $500 million of 6.00% senior secured notes due 2031 and another $500 million of 6.40% senior secured notes due 2036. The expected closing date is November 24, 2026,...

Continue Reading
BioArctic's Q3 Call Puts Leqembi Economics Under Watch

Updated Category News Views 32

One Date, Several Unanswered Questions November 25 lands with an unusually clean checklist for BioArctic watchers: results arrive at 8:00 a.m. CET, then management takes the floor at 9:30 a.m. CET. That is the whole immediate event, and it matters because this is not a company investors can sensibly judge by a single headline or a vague promise about neuroscience....

Continue Reading
Visual Cipher Bench Exposes AI Agents' Hidden Rule Gap

Updated Category News Views 0

Forty little black-and-white puzzles just threw a bucket of cold water on the autonomous-agent sales pitch. Einsia AI’s Navers Lab says its new Visual Cipher Bench found that the best result among eight frontier models was only 26.7%, with no tested configuration clearing 30%. That is not a minor blemish. It is a reminder that a model can sound clever, use tools, and...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 109

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
TRUSTA Targets AI Inference's GPU Memory Squeeze Hard

Updated Category News Views 69

GPU scarcity has turned ordinary server parts into strategic assets, and TRUSTA is leaning right into that uncomfortable fact at SuperComputing 2026. The enterprise-storage brand under ADATA is pitching an upgraded AI Scaler Toolkit built around a fairly sensible premise: companies running large-language-model inference should not have to buy another armful of expensive...

Continue Reading
Elisity’s Texas Water Pilot Puts IonQ’s Deal in View

Updated Category News Views 189

Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....

Continue Reading
Wonder Create: Democratizing Restaurant Creation

Updated Category News Views 135

Breaking Down Barriers in the Restaurant Industry It's been a long time since someone truly shook up the restaurant scene like this. Wonder Create is stepping in to turn anyone with a wild food idea into a bonafide restaurateur. We're not talking about the ol' franchising route here. We're diving straight into democratizing the culinary world. You seen something this bold...

Continue Reading
Scribd’s First Safety Report Shows Enforcement at Scale

Updated Category News Views 197

Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...

Continue Reading

Top 5 Most Recently Viewed Articles

Shell plc Announces Strategic Share Buybacks Amid Market Moves

Updated Category News Views 250

Shell plc Engages in Significant Share Buybacks Transaction in Own Shares Shell plc, a global leader in energy and petrochemical sectors, has undertaken a strategic initiative involving the purchase of its own shares for cancellation to optimize its capital structure. This decision aligns with the company’s broader strategy to enhance shareholder value through various...

Continue Reading
CSL Seqirus Strengthens Pandemic Readiness with New BARDA Award

Updated Category News Views 280

CSL Seqirus Receives Significant BARDA Award CSL Seqirus has recently received a noteworthy award from the Biomedical Advanced Research and Development Authority (BARDA). This grant is aimed at furthering the company's capabilities in preparing for potential pandemic situations through the development of avian influenza vaccines. The need for preparedness in public health...

Continue Reading
Navient’s Third Quarter Results: Financial Performance Insights

Updated Category News Views 86

Navient Announces Third Quarter 2024 Financial Results HERNDON, Va. — Navient (Nasdaq: NAVI) shared its third quarter financial results for 2024, showcasing the company’s ongoing commitment to providing innovative financial services and solutions. The comprehensive financial results are listed on the company's official site, ensuring transparency and accessibility for...

Continue Reading
Comstock Inc. Unveils Insights from 3Q24 Stakeholder Analysis

Updated Category News Views 169

Comstock Inc. (NYSE: LODE) dropped its Q3 2024 Stakeholder Perception Analysis Report, and you know how these things go—traders squinted at the numbers while trying to decipher what the hell it meant for their investments. So here's the deal: Comstock put out this report to show how its stakeholders felt about its performance and strategy, but really, it raised more...

Continue Reading
GraniteShares Unveils Innovative YieldBOOST Fund-of-Funds ETFs

Updated Category News Views 370

GraniteShares Introduces Unique Fund-of-Funds ETFs GraniteShares, an innovative leader in the ETF space, has recently introduced two new YieldBOOST Fund-of-Funds ETFs. These expansions reflect their commitment to offering cutting-edge investment solutions that cater to the evolving needs of investors. What Are the New ETFs? The two new offerings are the GraniteShares...

Continue Reading